![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pharma Equity Group A/s | LSE:0REU | London | Ordinary Share | DK0061155009 | PHARMA EQUITY GROUP ORD SHS |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.40 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Investors, Nec | 0 | -24.61M | -0.0241 | -16.60 | 409.19M |
2 June 2023
Announcement no. 33
Inside information
Settlement - purchase of shares
In connection with completion of Pharma Equity Group A/S' (the "Company") purchase of Reponex Pharmaceuticals A/S ("Reponex"), the new shares issued to former larger shareholders in Reponex were subject to a lock-up undertaking (the "Lock-Up Undertaking").
As a shareholder by mistake, and without having obtained consent from the Company, has divested shares in the Company in violation of the Lock-Up Undertaking, such shareholder has, as a consequence, undertaken towards the Company and the Company's board of directors to buy back in the market minimum 6,795,163 shares (with a nominal value of DKK 1.0 each). The share purchase shall be completed no later than on 21 June 2023.
For further information, please contact:
Thomas Kaas Selsø, CEO of Pharma Equity Group A/S, phone: 40 22 21 14
Peter M. Eriksen, Chair of the Board of Directors of Pharma Equity Group A/S, phone: 51 99 66 00.
1 Year Pharma Equity Group A/s Chart |
1 Month Pharma Equity Group A/s Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions